Src Inhibition with Saracatinib Reverses Fulvestrant sorted by
relevance

Admin23.07.2021

Src Inhibition with Saracatinib Reverses Fulvestrant

5207
Admin10.08.2021

Src Inhibition with Saracatinib Reverses Fulvestrant

7501
Admin26.07.2021

Figure 4 from Cancer Therapy : Preclinical Src Inhibition

3201
Admin03.08.2021

(PDF) Src Inhibition with Saracatinib Reverses Fulvestrant

6109
Admin19.09.2021

Src Inhibition with Saracatinib Reverses Fulvestrant

17010
Admin05.10.2021

(PDF) Src Inhibition with Saracatinib Reverses Fulvestrant

6002
Admin29.08.2021

Figure 1 from Cancer Therapy : Preclinical Src Inhibition

4003
Admin23.09.2021

Saracatinib increases ER protein levels and transcription

1806
Admin01.10.2021

Fulvestrant and saracatinib effects on MDA-MB-361 breast

2602
Admin29.09.2021

Estrogen activates Src, ER/Src binding, and ER

5702
Admin17.08.2021

Fulvestrant and saracatinib effects on MDA-MB-361 breast

96010
Admin24.09.2021

src inhibition attenuates gemcitabine resistance

9800
Admin11.08.2021

Src Inhibition with Saracatinib Reverses Fulvestrant

2203
Admin18.08.2021

src inhibition attenuates gemcitabine resistance

2309
Admin19.07.2021

Ls180 Cells | ATCC | Bioz

Admin07.10.2021

Src inhibition by Src siRNA induces melanogenesis and

52010
Admin23.08.2021

Src Inhibition Can Synergize with Gemcitabine and Reverse

9509
Admin04.08.2021

Fulvestrant and saracatinib effects on MDA-MB-361 breast

2703
Admin09.10.2021

Fulvestrant and saracatinib effects on MDA-MB-361 breast

8800
Admin23.09.2021

Inhibition of Src kinase reverses ERα overexpression

1200
Admin09.10.2021

(PDF) Inhibition of pp60c-Src reduces BCL-XL expression

4000